71 TARGETED DISRUPTION AND AGING-RELATED LOSS OF THE CARTILAGE SURFACE-SPECIFIC PROTEIN HMGB2 LEADS TO EARLY ONSET OSTEOARTHRITIS  by Taniguchi, N. et al.
C52 Podium Presentations
Abstract 70 – Table 1. Participant characteristics
No OA (N=126) OA (N=58) p-value
Age (Years) 67.2±1.29 72.6±1.32 0.004
Gender (M/F) 68/58 29/29 0.616
BMI (kg/m2) 27.1±0.421 27.7±0.603 0.441
Current Knee or Hip Pain N (%) 11 (8.7%) 19 (32.8%) <0.001
Knee or Hip Pain on Examination N (%) 25 (19.8%) 26 (44.8%) 0.001
Lean Mass of Right Leg by DXA (kg) (N=175) 15.6±3.62 15.2±3.48 0.433
Fat Mass of Right Leg by DXA (kg) (N=175) 4.48±1.80 4.77±2.29 0.356
Peroneal Nerve Conduction Velocity (m/s) 46.0±0.579 44.8±0.791 0.244
Figure 1. Average muscle density by OA status.
peripheral nerve function, but was substantially attenuated after
adjusting for total physical activity. Muscle density of the middle
thigh was signiﬁcantly lower in individuals with self-reported knee
or hip OA (p=0.014), but this relationship was fully explained by
the confounding effect of age (p=0.241). Peroneal nerve conduc-
tion velocity was not signiﬁcantly different between individuals
with self-reported OA and those without OA (p>0.05). Muscle
CSA, fat density, and lean and fat mass did not differ between
participants with self-reported OA compared to those without OA
(Table 1).
Conclusions: OA appears to be associated with lower middle
tibia muscle density, but not with changes in lean or fat mass. The
etiology and functional implications of lower muscle density in OA
are currently being evaluated. This study was fully supported by
the Intramural Research Program (IRP) of the National Institutes
of Health,-National Institute on Aging (NIA).
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Purpose: Osteoarthritis (OA) typically begins with an aging-
related disruption of the articular cartilage surface, followed by
progressive destruction and loss of cartilage. Mechanisms lead-
ing to the aging-related surface degeneration remain to be deter-
mined. In this study we demonstrate that the chromatin protein
HMGB2 is uniquely expressed in chondrocytes in the superﬁcial
zone of articular cartilage and determine the impact of Hmgb2
deﬁciency on cartilage homeostasis and OA pathogenesis.
Methods: Immunostaining was used to assess HMGB2 expres-
sion in human articular cartilage from younger (17-39 y.o.) and
older (61-85 y.o.) donors (N=6); and in C57Bl/6J mouse knee
joints at 3, 6, 9 and 15 months of age (N=6), respectively. Using
adult Hmgb2-/- mice at 3, 6, 9, 12 months old, knee joints were
examined by safranin O staining and OA grades were evalu-
ated by Mankin scoring. Cell death in articular cartilage was
examined by immunohistochemistry for apoptosis markers active
caspase-3 and parp-p85 and compared with the matrix degra-
dation markers MMP-3 and MMP-13. Superﬁcial zone protein
(SZP) in murine joints was examined by in situ hybridization.
Results: In normal human and murine knee articular cartilage
HMGB2 is exclusively expressed in the superﬁcial zone. In both
species there is an aging-related decline in HMGB2 expression,
ultimately leading to its complete absence and this is associated
with the development of structural lesions in the cartilage sur-
face. Mice with a targeted disruption of the HMGB2 gene have
normal development of the skeleton and joints. However, HMGB2
deﬁcient mice show early onset of osteoarthritis joint pathology.
In Hmgb2-/- mice there is increased parp-p85 at 6 months as-
sociated with a reduction in cellularity. MMP-3 is increased in
Hmgb2-/- at 6 months and reduced at 9 months while MMP-13 is
strongly expressed at 9 months. In Hmgb2-/- mice there is also
a reduction and early loss of SZP.
Conclusions: These ﬁndings identify HMGB2 as a factor specif-
ically expressed in superﬁcial zone chondrocytes and required
for cell survival and cartilage homeostasis. The aging-associated
loss of HMGB2 may be a novel trigger for the onset of OA.
The HMGB2 deﬁcient mouse represents a novel OA model that
recapitulates central features of the human disease.
